Skip to main content
. 2021 Jun 17;14:3769–3781. doi: 10.2147/OTT.S275322

Figure 1.

Figure 1

BGM inhibits the cell proliferation of melanoma cells. (AD) The WM239 and MM200 cells were treated with BGM at the indicated dose. (A and B) The cell viability was measured by CCK-8 assays in the WM239 and MM200 cells, respectively. (C and D) The cell proliferation was measured by colony formation assays in the WM239 and MM200 cells, respectively. Data are presented as mean ± SEM. Statistic significant differences were indicated: **P < 0.01, ***P < 0.001.